6533b838fe1ef96bd12a471b

RESEARCH PRODUCT

Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study

Markus GastparH.-j. MöllerG. BuchkremerHerbert PfeifferMarkus JägerMarkus JägerIsabella HeuserWolfgang MaierWolfgang GaebelLutz G. SchmidtDetlef DegnerG. LauxMax SchmaußMichael RiedelDieter NaberJoachim KlosterkötterMatthias R. Lemke

subject

AdultMalePredictive validitymedicine.medical_specialtyDrug trialAdolescentmedicine.medical_treatmentConsensus criteriaSensitivity and SpecificitySeverity of Illness Index03 medical and health sciences0302 clinical medicineNaturalistic observationInternational Classification of DiseasesInternal medicinemedicineHumans030212 general & internal medicinePsychiatryAntipsychoticAgedPsychiatric Status Rating ScalesPositive and Negative Syndrome ScaleReceiver operating characteristicPatient SelectionMiddle Agedmedicine.diseaseAntidepressive Agents030227 psychiatryPsychiatry and Mental healthTranquilizing AgentsTreatment OutcomeROC CurveSchizophreniaArea Under CurveSchizophreniaFemalePsychologyAntipsychotic AgentsFollow-Up Studies

description

AbstractObjectiveTo examine the predictive validity of early improvement in a naturalistic sample of inpatients and to identify the criterion that best defines early improvement.MethodsTwo hundred and forty-seven inpatients who fulfilled ICD-10 criteria for schizophrenia were assessed with the Positive And Negative Syndrome Scale (PANSS) at admission and at biweekly intervals until discharge from hospital. Remission was defined according to the recently proposed consensus criteria, response as a reduction of at least 40% in the PANNS total score from admission to discharge.ResultsReceiver operating characteristic (ROC) analyses showed that early improvement (reduction of the PANSS total score within the first 2 weeks of treatment) predicts remission (AUC = 0.659) and response (AUC = 0.737) at discharge. A 20% reduction in the PANSS total score within the first 2 weeks was the most accurate cut-off for the prediction of remission (total accuracy: 65%; sensitivity: 53%; specificity: 76%), and a 30% reduction the most accurate cut-off for the prediction of response (total accuracy: 76%; sensitivity: 47%; specificity: 90%).ConclusionThe findings of clinical drug trials that early improvement is a predictor of subsequent treatment response were replicated in a naturalistic sample. Further studies should examine whether patients without early improvement benefit from an early change of antipsychotic medication.

https://doi.org/10.1016/j.eurpsy.2009.02.005